Subfoveal choroidal thickness after brolucizumab therapy for neovascular age-related macular degeneration: a short-term multicenter study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Subfoveal choroidal thickness after brolucizumab therapy for neovascular age-related macular degeneration: a short-term multicenter study
Authors
Keywords
-
Journal
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-16
DOI
10.1007/s00417-021-05517-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Brolucizumab-related intraocular inflammation in Japanese patients with age-related macular degeneration: a short-term multicenter study
- (2021) Ichiro Maruko et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Short-term outcomes of intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 choroidal neovascularization including polypoidal choroidal vasculopathy
- (2021) Hidetaka Matsumoto et al. Scientific Reports
- Macular atrophy after aflibercept therapy for neovascular age-related macular degeneration: outcomes of Japanese multicenter study
- (2020) Hideki Koizumi et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- Spectral-Domain OCT Analysis of Risk Factors for Macular Atrophy Development in the HARBOR Study for Neovascular Age-Related Macular Degeneration
- (2020) SriniVas R. Sadda et al. OPHTHALMOLOGY
- Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion–Related Events with Brolucizumab
- (2020) Jordi Monés et al. OPHTHALMOLOGY
- HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
- (2019) Pravin U. Dugel et al. OPHTHALMOLOGY
- Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data
- (2019) Richard F. Spaide et al. OPHTHALMOLOGY
- Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy
- (2017) Masahiro Morimoto et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- MACULAR ATROPHY AND MACULAR MORPHOLOGY IN AFLIBERCEPT-TREATED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2017) Yoshimasa Kuroda et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Incidence and risk factors of retreatment after three-monthly aflibercept therapy for exudative age-related macular degeneration
- (2017) Wataru Kikushima et al. Scientific Reports
- Comparison of intravitreal aflibercept and ranibizumab injections on subfoveal and peripapillary choroidal thickness in eyes with neovascular age-related macular degeneration
- (2016) Cheolmin Yun et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration
- (2016) Hideki Koizumi et al. OPHTHALMOLOGY
- TREAT-AND-EXTEND REGIMEN WITH AFLIBERCEPT FOR RETINAL ANGIOMATOUS PROLIFERATION
- (2016) Hidetaka Matsumoto et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Short-Term Changes in Choroidal Thickness After Aflibercept Therapy for Neovascular Age-Related Macular Degeneration
- (2015) Hideki Koizumi et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Aflibercept therapy for polypoidal choroidal vasculopathy: short-term results of a multicentre study
- (2015) Hideki Koizumi et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Subfoveal choroidal thickness in polypoidal choroidal vasculopathy after switching to intravitreal aflibercept injection
- (2015) Masaaki Saito et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES
- (2015) K. Bailey Freund et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- SUBFOVEAL CHOROIDAL THICKNESS IN RETINAL ANGIOMATOUS PROLIFERATION
- (2014) Taizo Yamazaki et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
- (2014) Wan Ling Wong et al. Lancet Global Health
- Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
- (2012) Nicholas Papadopoulos et al. ANGIOGENESIS
- Subfoveal Choroidal Thickness after Ranibizumab Therapy for Neovascular Age-related Macular Degeneration: 12-Month Results
- (2012) Taizo Yamazaki et al. OPHTHALMOLOGY
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Subfoveal Retinal and Choroidal Thickness After Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
- (2011) Ichiro Maruko et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Tachyphylaxis during treatment of exudative age-related macular degeneration with ranibizumab
- (2011) Maria Salling Eghøj et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy
- (2011) Hideki Koizumi et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Choroidal Thickness in Polypoidal Choroidal Vasculopathy and Exudative Age-related Macular Degeneration
- (2011) Song Ee Chung et al. OPHTHALMOLOGY
- Enhanced Depth Imaging Spectral-Domain Optical Coherence Tomography
- (2008) Richard F. Spaide et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration
- (2007) Tien Wong et al. OPHTHALMOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now